RTW Investments makes investments in forward-thinking healthcare companies.
RTW Investments makes investments in forward-thinking healthcare companies. It invests across the entire company lifecycle, including company creation, early-stage venture capital, alternative financing, and public company investments. The company is headquartered in New York with offices in London and Shanghai.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 7, 2022
Apogee Therapeutics
|
Series B | $149M | Biotechnology | Yes |
Jul 18, 2022
Immunocore
|
Post-IPO Equity | $140M | Biotechnology | — |
Oct 7, 2021
Science 37
|
Post-IPO Equity | $200M | Biotechnology | — |
Oct 1, 2021
Roivant Sciences
|
Post-IPO Equity | $200M | Biopharma | — |
Aug 30, 2021
Rocket Pharmaceuticals
|
Post-IPO Equity | $26.40M | Biotechnology | Yes |